YAP1 and metabolic dysfunction-associated steatotic liver disease: Studies have demonstrated that curcumol can target YAP/NCOA4 to regulate ferritinophagy against hepatocyte senescence for the treatment of non-alcoholic fatty liver disease (NAFLD) [118].